Denelsky Stephen J

Denelsky Stephen J is listed in filings as Director at Harvard Bioscience, Inc.. This profile follows SEC Form 4 activity through Mar 18, 2026, including purchase activity. Recent filings connect the profile to Harvard Bioscience, Inc. (HBIO). The current snapshot covers public activity from Oct 7, 2025 to Mar 18, 2026. Reported amounts are shown as $48.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.